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The Visual Analogue Scale 8 (VAS8), consisting of eight linear scales, has been developed to measure health-related
quality of life (HRQoL) in chronic obstructive pulmonary disease (COPD) patients. The purpose of this study was
to examine the validity and responsiveness of the VAS8.
First, HRQoL was assessed in a cross-sectional study with the VAS8 and the St George’s Respiratory
Questionnaire (SGRQ) in 46 COPD patients. Relationships between the VAS8 and various physiological
parameters were examined. Second, in a longitudinal study, changes in HRQoL scores after pulmonary
rehabilitation were evaluated in 29 COPD patients.
The total VAS8 scores showed a weak correlation with vital capacity and maximal inspiratory pressure and a
moderately strong correlation with 6-min walking distance and dyspnoea rating. The total VAS8 score showed a
significant correlation with each SGRQ score. Furthermore, almost every VAS8 and SGRQ score improved
significantly after pulmonary rehabilitation. The change in the total VAS8 value showed a strong correlation with
that of the SGRQ.
The VAS8 is well-suited to assess HRQoL in COPD patients. Visual analogue scales are generally useful in
measuring HRQoL in COPD patients, and the VAS8 is particularly beneficial because of its ease of use.
Key words: health-related quality of life; Visual Analogue Scale; chronic obstructive pulmonary disease; pulmonary
rehabilitation.
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Evaluating health-related quality of life (HRQoL) or health
status has become an important consideration in the
treatment of patients with chronic obstructive pulmonary
disease (COPD) in the last decade. HRQoL instruments for
COPD patients include general health measures such as the
Sickness Impact Profile (SIP) (1) and the Medical Outcomes
Study ‘short-form’ 36 (SF-36) (2), and disease-specific
health measures such as the Chronic Respiratory Disease
Questionnaire (CRQ) (3) and the St. George’s Respiratory
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nagoya-u.ac.jp.0954-6111/00/121192+08 $35?00/0Questionnaire (SGRQ) (4). It has already been shown that
these questionnaires are precise, valid and responsive (4–7),
and they have been used for evaluation of HRQoL or
health status of patients with COPD in several clinical
studies. However, it often takes considerable time to
complete these items, especially for elderly patients.
Furthermore, calculating the scores is time-consuming
and complicated. Hiratsuka and Kida developed the Visual
Analogue Scale 8 (VAS8) as a measure of HRQoL in
patients with chronic pulmonary disabilities (8). The scale
was based on a quality of life (QoL) scale for patients with
advanced breast cancer (9). The VAS8 is simple and easy to
complete, however, its validity and responsiveness have not
yet been established. The purpose of this study was to
administer the VAS8 to patients with COPD and to
examine its validity by assessing the relationships between
the HRQoL score and various parameters including
pulmonary function, exercise capacity and dyspnoea# 2000 HARCOURT PUBLISHERS LTD
FIG. 1. Visual Analogue Scale 8 (VAS8). Patients were
asked to mark each line at the point which most
accurately described their feelings at that moment. The
distance, in millimeters, from the left end to the patient
mark provided the score out of 100. The total score was
the sum of the scores for each of these eight items out of a
possible 800. VAS8 was presented to patients in Japanese
and this shows only a translation. Work by a standard
method is required to develop the English version of the
VAS8. Reprinted and translated from (8).
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the SGRQ, the latter being one of the existing disease-
specific health measures for patients with COPD. We also
measured longitudinal changes in the VAS8 scores after
pulmonary rehabilitation to establish the responsiveness of
this assessment method.
Methods
CROSS-SECTIONAL STUDY
Patients
Patients with COPD, as defined by the American Thoracic
Society (10), were recruited from the outpatient pulmonary
clinic at Tosei General Hospital, Japan. Inclusion criteria
were as follows: a presence of chronic airflow limitation; no
history of asthma; a clinically stable condition during the
preceding 6 weeks and no changes in treatment regimen
during the preceding 4 weeks. Chronic airflow limitation
was defined as a maximal forced expiratory volume in 1 sec
(FEV1) / forced vital capacity (FVC) of ratio less than 0?7,
and FEV1 less than 70% of the predicted value. Patients
who could not perform the 6-min walking test or who
suffered from other severely disabling illnesses unrelated to
their respiratory disease, such as cardiovascular, neurolo-
gical and locomotor disease, were excluded from the study.
Patients using long-term oxygen therapy (LTOT) at the
time of this study were also excluded. All eligible patients
finished the following examinations in the same day:
pulmonary function tests, 6-min walking tests, arterial
blood gas analysis at rest, inspiratory muscle tests,
assessment of HRQoL and assessment of dyspnoea.
Informed consent was obtained from all patients.
Pulmonary function tests
Inhalation of b-receptor agonists and anti-cholinergic drugs
was withheld for at least 12 h before pulmonary function
tests were performed. Sustained released theophyline was
administered in the same doses throughout the study.
Spirometric flow–volume curves were recorded according
to the method described in the American Thoracic Society
1994 update (11). Patients were tested using a spirometer
(CHESTAC-55V; Chest, Tokyo, Japan). The predicted
values for FEV1 and vital capacity (VC) were calculated
according to the formula proposed by the Japan Society of
Chest Diseases (12).
Six-minute walking test
Exercise performance was evaluated by a 6-min walking
test, which was performed in a hospital corridor. Patients
were asked to walk as far as possible in 6min. They could
determine their own pace, even stop if necessary, and they
were instructed that at the end they should feel as though
they could not have walked any further. The distance thepatients could walk in 6min was recorded. The tests were
performed at least twice in the same day and the maximum
values were determined to be the 6-min walk distance. The
predicted values for the 6-min walk were calculated
according to the equations proposed by Enright and
Sherrill (13).
Inspiratory muscle tests
Maximal inspiratory mouth pressure was measured at
residual volume (RV) in a quasistatic manner, according to
the method proposed by Black and Hyatt (14), using a
VITALOPOWER KH101 (Chest). Peak maximal inspira-
tory pressure (PImax) was recorded, and the highest value of
at least three manoeuvres was employed.
Assessment of HRQoL (health status)
The HRQoL was assessed by the VAS8 and the Japanese
version of the SGRQ, which was previously validated (15).
Permission for use was obtained from the original
investigators. The VAS8 developed by Hiratsuka and Kida
covers aspects of emotion, respiratory symptoms and daily
activity, and consists of the following eight variables: feeling
of well-being, mood, anxiety, dyspnoea, headache, appetite,
housework or job and social activity. Briefly, a 10 cm line
was given for each item, with the ends of the lines labelled
with words descriptive of extremes of the item (Fig. 1).
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most appropriate to describe their feelings at that moment.
The distance, in millimetres, from the left end to the
examinee’s mark provided the score out of 100. The total
score was the sum of the scores for each of these eight items
out of a possible 800. The VAS8 was actually administered
to patients in Japanese and Fig. 1 shows only a translation
of the VAS8. The SGRQ has 76 items which are weighted
to produce three component scores (symptoms, activity and
impact) and a total score. Each of these scores ranges from
0 to 100; a score of 100 indicates maximal disability.
Assessment of dyspnoea
To assess dyspnoea, the Japanese version of the baseline
dyspnoea index (BDI) (16), previously validated (15), was
used. The BDI recognizes five grades for each of the
following categories: functional impairment, magnitude of
task and magnitude of effort.
LONGITUDINAL STUDY
Patients
We evaluated the longitudinal changes in HRQoL scores
after pulmonary rehabilitation. Patients who could undergo
our pulmonary rehabilitation programme were recruited
from patients in the cross-sectional study and allocated to
the longitudinal study. This study was performed as part of
our standard outpatient care and informed consent was
obtained from all patients. Subjects for this study were
enrolled during the same time frame as the cross-sectional
study.
Pulmonary rehabilitation programme
Our pulmonary rehabilitation programme included exercise
training, strength training of peripheral muscle and
respiratory muscle training. Exercise training was per-
formed using treadmill walking for 30min. Training
intensity was targeted at 60–90% of the predicted maximal
heart rate (2207age) (17). When desaturation (O2 satura-
tion 588%) was observed, oxygen was delivered during
exercise by nasal cannula at a sucient rate to achieve O2
saturation of 90% or above. Respiratory muscle training
was performed using THRESHOLD (Chest). It was
generally initiated at low intensities, not less than 30% of
PImax, then gradually increased. The strength training
programme included two different exercises which were
performed with the following weight-lifting procedures: a
bilateral movement combining elbow flexion and shoulder
adduction (mainly for the latissimus dorsi) and a bilateral
knee extension (mainly for the vastus lateralis muscle).
Exercise sessions were held 2 days per week at our
pulmonary rehabilitation centre for a total of 8weeks.
Patients were instructed to do the respiratory muscle
training twice every day at home.Outcome measures
The HRQoL was assessed with the VAS8 and the SGRQ at
baseline and again 3months after the initiation of the
pulmonary rehabilitation programme to establish VAS8
responsiveness. At the same time, pulmonary function, 6-
min walking distance, PImax and BDI score were assessed.
The recording methods were exactly the same as the cross-
sectional study. Initial drug treatment did not change
during the study period.
STATISTICAL ANALYSIS
Cronbach’s reliability coecient a was used to assess the
internal consistency of the VAS8 and the SGRQ. Cronba-
ch’s a40?7 was taken to be reliable. Pearson’s correlation
coecients (r) were determined to examine the degree of
correlation among components of the HRQoL scores,
pulmonary functions, 6-min walking distance, arterial
blood gas analysis, PImax, and the BDI score. Multiple
linear regression analyses were performed to evaluate the
individual contribution of physiological parameters includ-
ing VC, FEV1, PaO2, PaCO2, PImax, 6-min walking distance,
and the BDI score (independent variables) to the eight
components of the VAS8 and the total score (dependent
variable). Content validity of the dimensions of the VAS8
was assessed by correlating these dimensions with compar-
able dimensions of the SGRQ (Pearson’s correlation
coecient, r). Changes in the physiological parameters
were analysed with a paired t-test. A P-value of less than
0?05 was considered significant. Values are presented as
mean+SD.
Results
CROSS-SECTIONAL STUDY
Between June 1997 and May 1999, 46 patients were
recruited into our cross-sectional study. Pulmonary func-
tion tests, exercise performance, demographic details, and
scores on the VAS8 and SGRQ are shown in Table 1.
The internal consistency reliability coecient of the
VAS8 and the total scores for the SGRQ were high
(a=0?85 and 0?80, respectively). The frequency distribution
histograms of the total of the VAS8 and the SGRQ are
shown in Fig. 2. The SGRQ scores were normally
distributed. The VAS8 had a somewhat more inferior
distribution than the SGRQ.
Pearson’s correlation coecients were obtained to
investigate relationships between scores of each variable
of the HRQoL questionnaires and various factors as shown
in Tables 2 and 3. With regard to the total score, VAS8
showed a significant correlation with VC as percent
predicted (r=0?30), 6-min walking distance as percent
predicted (r=0?57), PImax as percent predicted (r=0?31),
and the BDI score (r=0?55). The total score of the SGRQ
showed significant correlations with the FEV1 (r=70?42),
6-min walking distance (r=70?42), and BDI score
TABLE 1. Clinical characteristics of 46 patients with COPD
Mean+SD Range
Gender (M/F) 39 / 7
Age (years) 70?7+7?3 46–84
VC (l) 2?48+0?64 1?13–4?15
VC (% predicted) 81?9+15?6 40?2–120?3
FEV1 (l) 0?81+0?29 0?43–1?87
FEV1 (% predicted) 39?5+11?9 18?2–69?5
FEV1/FVC (l) 35?8+7?6 23?1–51?9
PaO2 (mmHg) 79?9+10?0 58?3–101?1
PaCO2 (mmHg) 37?4+5?1 24?7–53?2
6 MWD (m) 385+105 166–580
6 MWD (% predicted) 83?8+22?4 34?9–120?7
PImax (cmH2O) 69?2+25?2 24?5–152?5
PImax (% predicted) 71?0+25?0 24?6–148?3
BDI score 6?4+1?9 1–10
VAS 8
Feeling of well being [0–100] 51?8+27?4 0–100
Mood [0–100] 52?3+26?1 0–99
Anxiety [0–100] 52?4+28?6 4–100
Dyspnoea [0–100] 45?5+24?4 4–99
Headache [0–100] 74?0+33?0 0–100
Appetite [0–100] 64?6+27?7 0–100
Housework or job [0–100] 54?6+28?6 0–100
Social activity [0–100] 37?5+30?2 0–99
Total [0–800] 433+158 122–722
SGRQ
Symptoms [0–100] 62?1+18?1 21?1–95?3
Activity [0–100] 72?2+16?8 23?5–100
Impacts [0–100] 40?8+17?2 3?6–74?4
Total [0–100] 53?9+15?1 19?9–80?2
Abbreviations: 6 MWD: 6-min walking distance; PImax:
peak maximal inspiratory pressure; BDI: baseline dyspnoea
index; VAS8: Visual Analogue Scale 8; SGRQ: St George’s
Respiratory Questionnaire.
FIG. 2. Frequency distribution histograms of total scores
for the VAS8 and the SGRQ. In the VAS8, a higher score
indicates better health. In the SGRQ, a higher score
indicates poor health. Numbers in parentheses represent
the theoretical score range.
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The pattern of correlation between the VAS8 score and
various parameters was similar to that for the SGRQ.
Stepwise multiple regression analyses were used to
identify variables that could best predict HRQoL evaluated
by the VAS8 (Table 4). Both the BDI score and 6-min
walking distance were significant independent predictors of
the total score. Other results of the analyses are shown in
Table 4.
Pearson’s correlation coecients between the VAS8 and
the SGRQ are shown in Table 5. The total VAS8 score
showed significant correlations with all of the SGRQ
scores. Other results of the analyses are shown in Table 5.
LONGITUDINAL STUDY
Twenty-nine patients were recruited into our longitudinal
study. A significant increase in VC as percent predicted was
observed, from 83?4+15?4% to 87?4+15?8% (P50?05),with no changes in FEV1 as percent predicted, PaO2, and
PaCO2 (40?4+12?5% vs. 41?7+13?6%, 81?7+8?6 vs.
81?3+12?5 and 37?0+5?0 vs. 37?1+7?0, respectively). Six-
minute walking distance and BDI score showed significant
improvements over the 3-month period (Table 6). As for
HRQoL, each dimension of the VAS8 and SGRQ scores
significantly improved, except for the score of housework or
job in the VAS8 (Table 6). The change in the total VAS8
score showed a significant correlation with the change in
the total SGRQ score (r=70?577, P50?001) (Fig. 3). The
correlation between the change in the total VAS8 score and
the 6-min walking distance was also found to be statistically
significant (r=0?412, P50?05). However, the change in the
total SGRQ score had no significant correlation with the
change in 6-min walking distance (r=70?282). The change
in the total VAS8 scores showed significant correlation with
the change in the BDI score (r= 0?577, P50?001),
although the change in the total SGRQ scores did not
show significant correlation with the change in the BDI
score (r=70?341).
Discussion
In 1993, Hiratsuka and Kida developed the VAS8 as a
measure of HRQoL in patients with chronic pulmonary
TABLE 2. Pearson’s correlation coecients between the scores of the VAS8 and other variables in 46 patients with COPD
Feeling of
well-being
Mood Anxiety Dyspnoea Headache Appetite Housework
or job
Social
activity
Total
VC (% predicted) 0?36{ — — — — 0?29{ 0?32{ — 0?30{
FEV1 (% predicted) — — — 0?38
{ — — — — —
PaO2 — — — — — — — — —
PaCO2 — — — — — — — — —
6 MWD (% predicted) 0?48* 0?42* 0?33{ — 0?40* 0?45* 0?40* 0?43* 0?57*
PImax (% predicted) — — — 0?30
{ — 0?36{ — — 0?31{
BDI score 0?60* 0?40* 0?43* 0?31{ — 0?36{ 0?41* 0?40{ 0?55*
All values listed represent statistically significant relationships ({P50?05, *P50?01); missing values indicate no significant
relationship.
TABLE 3. Pearson’s correlation coecients between the scores of the SGRQ and other variables in 46 patients with COPD
Symptoms Activity Impacts Total
VC (% predicted) — 70?32{ 70?45* —
FEV1 (% predicted) — — 70?38* 0?38
{
PaO2 — — — —
PaCO2 0?34
{ — — —
6 MWD (% predicted) 70?39* 70?58* 0?33{ 70?42*
PImax (% predicted) — — — —
BDI score 70?51* 70?61* 0?43* 70?56*
All values listed represent statistically significant relationships ({P50?05, *P50?01); missing values indicate no significant
relationship.
TABLE 4. Results of the stepwise multiple regression analyses
Feeling of
well-being
Mood Anxiety Dyspnoea Headache Appetite Housework
or job
Social
activity
Total
Independent Variables
VC (% predicted) — — — — — — — — —
FEV1 (% predicted) — — — — — — — — —
PaO2 — — — — — — — — —
PaCO2 — — — — — — — — —
6 MWD (% predicted) — 0?18 — — 0?16 — — 0?18 0?22
PImax (% predicted) — — — — — — — — —
BDI score 0?36 — 0?19 0?10 — 0?20 0?17 — 0?17
Cumulative R2 0?36 0?18 0?19 0?10 0?16 0?20 0?17 0?18 0?39
All values listed represent the coecient of determination (R2). Missing values indicate that independent variables were not
statistically significant.
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advanced breast cancer (9). The VAS8 is simple and easy to
complete and calculate so it is well-suited to any setting
where time is limited, such as an outpatient clinic.
Hiratsuka and Kida showed that the VAS8 had good
repeatability and indicated its reliability (8); however, its
validity and responsiveness had not yet been established.
The present study demonstrated that the VAS8 was validand responsive compared with the SGRQ, which is one of
the representative HRQoL questionnaires. Therefore, we
considered that the VAS8 can facilitate HRQoL assessment
for COPD patients in situations where time is limited.
In the cross-sectional analysis, our results show a high
internal consistency reliability for the VAS8. However, the
VAS8 had a somewhat more inferior distribution than the
SGRQ. This lower discriminative power of the VAS8 can
TABLE 5. Pearson’s correlation coecients between the VAS8 and the SGRQ in 46 patients with COPD
VAS8 Feeling of
well-being
Mood Anxiety Dyspnoea Headache Appetite Housework
or job
Social
activity
Total
SGRQ
Symptoms 70?35{ – 70?35{ 70?35{ – – – 70?33{ 70?42*
Activity 70?52* 70?51* 70?45* 70?47* 70?42* 70?41* 70?52* 70?52* 70?69*
Impacts 70?56* 70?57* 70?57* 70?48* 70?35{ 70?53* 70?46* 70?45* 70?71*
Total 70?58* 70?56* 70?56* 70?52* 70?40* 70?51* 70?50* 70?51* 70?74*
All values listed represent statistically significant relationships ({P50?05, *P50?01); missing values indicate no significant
relationship.
TABLE 6. Changes in the HRQoL scores and other variables
in 29 patients with COPD after pulmonary rehabilitation
Before After
VAS8
Feeling of well-being 54+29 64+28{
Mood 48+27 61+27*
Anxiety 51+28 69+27*
Dyspnoea 43+22 66+27*
Headache 71+36 83+31{
Appetite 60+29 69+27{
Housework or job 54+29 56+29
Social activity 30+29 45+30{
Total 413+154 513+170*
SGRQ
Symptoms 63?1+19?0 54?7+18?1{
Activity 73?4+12?3 64?7+15?8*
Impacts 42?3+16?3 31?7+16?7*
Total 55?2+13?3 45?5+14?6*
6 MWD (% predicted) 82?0+23?9 92?3+20?9*
BDI score 7+2 8+1*
{Statistically significant relationships at P50?05; *statisti-
cally significant relationships at P50?01.
FIG. 3. Scatterplots of the change in the total scores of the
VAS8 (DVAS8) and the total scores of the SGRQ
(DSGRQ).
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only eight variables. With respect to relationships between
VAS8 variables and various physiological parameters,
expected information regarding HRQoL scores was ob-
tained, showing a weak correlation with pulmonary
function, moderate-to-strong correlation with BDI score
and no significant relationship with arterial blood gas
tensions. Similar results were observed in the relationships
between the SGRQ and physiological parameters. In
addition, stepwise multiple regression analyses showed that
the BDI score was a significant predictor of five of the eight
VAS8 variables. These results are similar to those of
previous studies for HRQoL in patients with COPD
(4,6,7,15,18–20). Furthermore, each VAS8 variable was
significantly correlated with most SGRQ dimensions. As
described by Guyatt et al., an instrument is valid if its
results correspond to those of criterion standards (21). The
results of our study provide evidence for the validity of theVAS8 to measure HRQoL or heath status in patients with
COPD.
We also assessed the improvement of HRQoL after
pulmonary rehabilitation to investigate the responsiveness
of the VAS8. The responsiveness of the VAS8 was also
evaluated by comparing it with the SGRQ, which has
already been shown to be responsive (4). Pulmonary
rehabilitation for patients with COPD has been shown to
improve HRQoL (22), and there are also number of studies
that demonstrate the beneficial effect of pulmonary
rehabilitation on exercise capacity (23,24). In this study,
HRQoL as assessed by the VAS8, 6-min walking distance
and the BDI score improved. This result is consistent with
those of previous reports. The change in the total scores of
the VAS8 showed a significant correlation with both change
in dyspnoea assessed by the BDI score and the change in 6-
min walking distance. Furthermore, the change in the total
VAS8 score was significantly correlated with that of the
SGRQ. Given that the SGRQ is a standard disease specific
instrument for evaluating changes in the HRQoL, these
findings substantiate the responsiveness of the VAS8.
The SGRQ is weighted and the weights appear to be
valid (4,25). However, the SGRQ is sometimes dicult to
1198 O. NISHIYAMA ET AL.complete because of its length and the use of complicated
sentences, particularly for elderly patients, therefore it is
generally time-consuming to use it in situations where time
is limited, such as outpatient clinics. The same can be said
for other questionnaires previously discussed, such as the
CRQ. On the other hand, the VAS8 is easily understood
and not as time-consuming. It is easily administrable to
patients even at outpatient clinics and takes less than 5min
to complete.
While a visual analogue scale has proven useful in the
measurement of breathlessness (26–28), there have been
only a limited number of studies testing visual analogue
HRQoL assessments for COPD patients. The present study
confirms not only the validity of VAS8 but also that a
visual analogue scale is useful in measuring HRQoL or
health status in patients with COPD.
The limitations of our assessment must be acknowledged.
First, only patients not using LTOT were enrolled and
therefore some of the more severe cases may have been
excluded, which might have caused HRQoL to appear
worse. Actually, it is unclear whether the VAS8 can
effectively measure HRQoL in more severe cases. Second,
in the longitudinal study, we evaluated the responsiveness
to improvements rather than deteriorations because we
assessed the change of HRQoL after pulmonary rehabilita-
tion. Therefore, we must mention our bias in assessing only
improvements (29). Further study is required to evaluate
the responsiveness to deteriorations. We should also assess
the responsiveness of the VAS8 after comprehensive
medical interventions. Lastly, our study population pre-
dominantly consisted of men, so generalization of the
results to women with COPD may not be accurate.
We conclude that the VAS8 is a valid and responsive
measurement for assessing HRQoL or health status in
patients with COPD and that a visual analogue scale is
useful to measure HRQoL in those patients. We therefore
believe that the VAS8 can facilitate HRQoL assessment for
COPD patients in clinical situations.
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